FDA Appeals Death Penalty Drug Ban To DC Circ.

Law360, New York (May 25, 2012, 7:57 PM EDT) -- The U.S. Food and Drug Administration asked the D.C. Circuit on Friday to review a decision in favor of death row prisoners who sued the agency in order to halt the importation of an unapproved drug used to carry out executions.

The prisoners lodged their case in Washington federal court in February 2011, arguing the FDA must deny admission to sodium thiopental as it would any drug that is unapproved, misbranded or adulterated. Allowing shipments of sodium thiopental to enter the U.S. is a violation of...
To view the full article, register now.